World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   8790 records for 1410 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02743689
Perioperative Risk Factors for Intensive Care Delirium After Cardiac Surgery
13/04/2016
RecruitingRBR-93gkd4
Efficacy and safety of Eslicarbazepine Acetate (BIA 2-093) as single therapy for patients with newly diagnosed partial-onset seizures - ESL extension study
11/03/2016
AuthorisedEUCTR2014-004048-36-HU
This study is to determine if ranibizumab injected into the eye is superior to laser therapy in the treatment of retinopathy of prematurity (ROP). The study will assess the ability of these treatments to lead to regression of active ROP and prevent the development of ocular complications that are associated with poor visual outcome.
10/03/2016
AuthorisedEUCTR2015-004068-13-LV
Study investigating PEGylated Recombinant Human Hyaluronidase (PEGPH20) in previously untreated patients with pancreatic cancer that have high levels of hyaluronan. The study has two groups: all patients will be treated with nab-Paclitaxel plus Gemcitabine. In addition, one group will receive PEGPH20 and the other group will receive an inactive substance. Neither the patient nor the doctor will know the treatment group in which the patient has been randomly assigned to. 16/02/2016
AuthorisedEUCTR2015-002876-25-LT
A study to investigate how effective and safe the study medication ‘mirabegron’ is and how long it stays in the body in children and adolescents aged 5 to less than 18 years with symptoms of an overactive bladder with a neurologic cause. P/0117/2015 of 05Jun2015
28/01/2016
RecruitingNCT02670083
CREAD Study" A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
28/01/2016
RecruitingNCT02699736
Clinical and Virological Outcome of European Patients Infected With HIV
19/01/2016
RecruitingNCT02657434
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer [IMpower 132] 14/01/2016
AuthorisedEUCTR2015-004440-19-LT
Clofazimine treatment of multidrug-resistant tuberculosis (MDRTB)
31/12/2015
AuthorisedEUCTR2015-003372-73-HU
A clinical trial to evaluate the safety and efficacy of ZTI-01 versus Piperacillin/Tazobactam in hospitalized patients with complicated urinary tract infections. 29/12/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history